marimastat has been researched along with Colonic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hall, AR; Rajan, SAP; Skardal, A | 1 |
| Courtney, A; Cox, J; Hays, S; Kebart, R; Meyer, W; Nemunaitis, J; Ognoskie, N; Rasmussen, H; Tong, A; Yu, Y | 1 |
1 trial(s) available for marimastat and Colonic Neoplasms
| Article | Year |
|---|---|
Prognostic role of K-ras in patients with progressive colon cancer who received treatment with Marimastat (BB2516).
Topics: Adult; Aged; Aged, 80 and over; Colonic Neoplasms; DNA Mutational Analysis; DNA, Neoplasm; Drug Resistance, Neoplasm; Enzyme Inhibitors; Female; Genes, ras; Humans; Hydroxamic Acids; Male; Middle Aged; Polymerase Chain Reaction; Predictive Value of Tests; Prognosis; Sequence Analysis, DNA; Survival Analysis | 2000 |
1 other study(ies) available for marimastat and Colonic Neoplasms
| Article | Year |
|---|---|
Multi-Domain Photopatterned 3D Tumor Constructs in a Micro-Physiological System for Analysis, Quantification, and Isolation of Infiltrating Cells.
Topics: Caco-2 Cells; Cell Separation; Colonic Neoplasms; Fluorouracil; HCT116 Cells; Humans; Hydrogels; Hydroxamic Acids; Lab-On-A-Chip Devices; Neoplasm Invasiveness; Neoplasm Metastasis | 2020 |